AngioDynamics (ANGO) Tops Q3 EPS by 4c, Reaffirms FY Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.67 -1.14%
Financial Fact:
Sales and marketing: 19.49M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Sales and marketing: 19.49M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.03, $0.04 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $74 million versus the consensus estimate of $76.32 million.
GUIDANCE:
AngioDynamics sees FY2022 EPS of ($0.02)-$0.02, versus the consensus of ($0.01). AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $313.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
